DNAVEC Corporation

Start Date End Date Funded Value Relevance

CSV

25 50 100

£1,280,829

Mar 12 - Oct 13

Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis

MRC award to University of Oxford and Deborah Gill

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}